45 research outputs found
Underneath the Arches, no. 61, October 24, 1968
Underneath the Arches was Grand Valley State\u27s faculty and staff newsletter, published from 1963 to 1971. It was a precursor to the Forum
Representative immunohistochemical stainings.
<p>CD31 (A, B; microvascular density), Ki-67 (C, D; cell proliferation), TUNEL (E, F; apoptosis) and VEGFR2 expression (G,H) in the therapy (left column: A, C, E, G) and in the control group (right column: B, D, F, H). Note the significant lower (p < 0.01) microvascular density, tumor cell proliferation and VEGFR2 expression and the significant higher (p < 0.01) apoptosis rate in the therapy group. Scale bar in images represents 100 渭m.</p
Line regression analysis for the correlation between CEUS parameter of VEGFR2-specific binding and immunohistochemical VEGFR2 expression.
<p>Note the significant correlation between the values of SI<sub>8min</sub> and the number of VEGFR2 positive stained vessels (Spearman麓s 蟻 = 0.66, p = 0.003) for the therapy and the control group.</p
Column charts of SI<sub>10min</sub> in the therapy and control group at follow-up.
<p>Note the significant difference (p < 0.05) between the mean values of SI<sub>10min</sub> between the therapy and the control group at the follow-up.</p
Influence of long CAG and age on cerebral gray matter.
<p><b>Note.</b> L, left; R, right;</p><p>*corrected P value at the set level, 0.023.</p
Representative CEUS images of a rat with a subcutaneous tumor xenograft (white arrows) under treatment.
<p>Therapy group (red) and control group (blue) at baseline and follow-up. Left side: early vascular phase with BR55 as a functional imaging biomarker; right side: late phase of VEGFR2-specific binding with BR55 as a molecular imaging biomarker 8 minutes after contrast injection. Note the significant lower number of circulating microbubbles in the early vascular phase as well as the significant lower number of bound microbubbles in the late phase at follow-up in the therapy group, compared to baseline and compared to the control group.</p